A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with <scp>HCC</scp>-Reference-Cited by-同舟云学术

A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC

Published:2022-10-26 Issue:12 Volume:42 Page:2843-2854
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Larrey Edouard¹,Campion Bertille¹,Evain Manon¹,Sultanik Philippe¹^ORCID,Blaise Lorraine²,Giudicelli Héloïse¹,Wagner Mathilde³,Cluzel Philippe⁴,Rudler Marika¹⁵,Ganne‐Carrié Nathalie²⁶,Thabut Dominique¹⁵,Allaire Manon¹⁶^ORCID

Affiliation:

1. AP‐HP Sorbonne Université, Hôpital Universitaire Pitié‐Salpêtrière, Service d'Hépato‐gastroentérologie Paris France

2. AP‐HP Sorbonne Paris Nord, Hôpitaux Universitaire Paris Seine Saint‐Denis, Service d'Hépatologie Bobigny France

3. AP‐HP Sorbonne Université, Hôpital Universitaire Pitié‐Salpêtrière, Service de radiologie diagnostique Paris France

4. AP‐HP Sorbonne Université, Hôpital Universitaire Pitié‐Salpêtrière, Service de radiologie interventionnelle Paris France

5. Sorbonne Université, INSERM, Centre de recherche Saint‐Antoine (CRSA), Institute of Cardiometabolism and Nutrition (ICAN) Paris France

6. INSERM UMR 1138, Centre de recherche des Cordeliers Paris France

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15458

Reference25 articles.

1. Portal hypertension and hepatocellular carcinoma: Des liaisons dangereuses…

2. Prevalence and Prognostic Significance of the Presence of Esophageal Varices in Patients With Hepatocellular Carcinoma

3. Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy

4. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis

5. Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab;Digestive and Liver Disease;2024-09

2. Management of patients with advanced HCC receiving atezolizumab/bevacizumab: Take care of cirrhosis!;Hepatology;2024-08-05

3. Heterogeneity in adverse events related to Atezolizumab-Bevacizumab for hepatocellular carcinoma reported in real-life studies;JHEP Reports;2024-08

4. Screening for exclusion of high-risk bleeding features of esophageal varices in cirrhosis through CT and MRI;Clinical Imaging;2024-06

5. Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition);Liver Research;2024-06